
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 9.030 | 9.030 | 0.000 |
Shares | 91.660 | 91.660 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 27.137 | 26.300 |
Price to Book | 3.197 | 3.288 |
Price to Sales | 5.212 | 4.479 |
Price to Cash Flow | 20.067 | 20.099 |
Dividend Yield | 3.633 | 2.136 |
5 Years Earnings Growth | 7.879 | 8.150 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 97.350 | 96.666 |
Consumer Defensive | 2.640 | 2.828 |
Technology | 0.010 | 0.481 |
Number of long holdings: 33
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
InventisBio | CNE100005Q22 | 7.56 | 31.11 | +0.58% | |
Tasly Pharm | CNE000001C81 | 5.06 | 15.80 | +1.02% | |
APT Medical | CNE100004C45 | 4.92 | 316.73 | +1.05% | |
Salubris Pharm A | CNE100000FW8 | 4.23 | 60.35 | +1.67% | |
WuXi AppTec | CNE1000031K4 | 4.06 | 112.03 | +6.42% | |
Gan Lee Pharmaceuticals | CNE100003ZH1 | 3.98 | 75.90 | -0.62% | |
Shanghai MicroPort EP Medtech | CNE100005PG9 | 3.70 | 22.13 | +0.87% | |
Cr Sanjiu A | CNE0000011K8 | 3.41 | 28.09 | -0.46% | |
Jiangzhong Pharm | CNE000000M80 | 3.32 | 21.93 | -0.09% | |
Sunflower Pharma | CNE100001WT7 | 3.20 | 15.27 | -0.65% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Changsheng Quantification Of Divide | 998.92M | 0.21 | 6.36 | 12.78 | ||
ChangSheng Electronic Infor Ser St | 957.16M | 31.79 | 1.23 | 2.38 | ||
Changsheng Tongde Thematic Growth F | 789.31M | 26.66 | 4.49 | 5.31 | ||
Advanced Equipment Manufacturing Ba | 768.3M | 41.67 | 13.12 | 14.54 | ||
Changsheng CSI 300 index Fund | 415.97M | 12.92 | 5.57 | 7.03 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review